Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • South Carolina guideSouth Carolina Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFPChoosing and Responding to Government Bids
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›South Carolina
  4. ›Healthcare and Medical Services
  5. ›Cancer Benefits

State Fiscal Accountability Authority·South Carolina

Cancer Benefits

Closes 1/26/2026$500k – $5MRequest for Proposal
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The State Fiscal Accountability Authority is seeking proposals for cancer benefits. The solicitation is for cancer benefits, but the exact scope of work is not specified in the provided document. However, it can be inferred that the contractor will be responsible for providing cancer-related services or benefits. Key points to consider: • The pre-bid conference will be held on January 6, 2026, at 10:00 AM via teleconference. • The bid submission deadline is January 26, 2026, at 11:00 AM. • The procurement officer is Elizabeth McWhorter, and she can be contacted for instructions on attending the pre-bid conference. • The full details of the solicitation can be downloaded from the provided link.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Elizabeth McWhorter(Procurement Officer)

[email protected]

(803) 737-4994

Key dates

Opened
12/17/2025
Pre-bid meeting
1/6/2026
Closes
1/26/2026

Last updated

Details

Type
Request for Proposal
Industry
Healthcare and Medical Services
NAICS
621110
Solicitation №
5400029018

Budget estimate

$500,000 – $5,000,000

The budget for this opportunity is difficult to estimate without more information on the scope of work. However, considering the nature of cancer benefits, it is likely that the contract value will be substantial. Factors that may influence the likely payment range include the number of individuals covered, the extent of benefits provided, and the duration of the contract. A rough estimate for the contract value could be between $500,000 and $5,000,000, depending on the specifics of the proposal.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 69%

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 9/5/2024

U.S. National Institutes of Health·United States of America

68% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

68% match

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

68% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. Centers for Disease Control - NCCDPHP·United States of America

68% match

Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations

Closes 3/6/2027Opened 9/14/2026

U.S. Centers for Disease Control - NCCDPHP·United States of America

68% match

Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations

Closes 2/5/2027Opened 9/3/2026

U.S. Centers for Disease Control - NCCDPHP·United States of America

67% match

Promoting Cancer Surveillance Workforce, Education, and Data Use

Closes 4/6/2027Opened 9/28/2026

U.S. National Institutes of Health·United States of America

67% match

Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 6/16/2025

U.S. National Institutes of Health·United States of America

66% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Closes 11/17/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

66% match

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Closes 1/24/2027Opened 3/10/2026

U.S. National Institutes of Health·United States of America

66% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Closes 11/6/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

66% match

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/23/2023

U.S. National Institutes of Health·United States of America

66% match

Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Closes 6/10/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

66% match

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Closes 9/7/2028Opened 11/12/2024

U.S. National Institutes of Health·United States of America

65% match

Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)

Closes 1/25/2027Opened 8/28/2025

U.S. National Institutes of Health·United States of America

65% match

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/15/2023

U.S. National Institutes of Health·United States of America

65% match

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 9/5/2024

U.S. National Institutes of Health·United States of America

65% match

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

Closes 1/7/2027Opened 8/24/2023

U.S. National Institutes of Health·United States of America

65% match

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Closes 2/11/2028Opened 11/7/2024

U.S. National Institutes of Health·United States of America

65% match

Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)

Closes 1/24/2027Opened 6/2/2026

U.S. National Institutes of Health·United States of America

65% match

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Closes 9/25/2028Opened 11/26/2025

Mississippi Department of Health·Mississippi

64% match

Cancer Survivorship Evaluation

Closes 11/2/2026Opened 10/13/2026

U.S. National Institutes of Health·United States of America

64% match

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 11/18/2024

U.S. National Institutes of Health·United States of America

64% match

Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 11/18/2024

U.S. National Institutes of Health·United States of America

64% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026